Cantrell Drug Recalls Heparin Sodium Syringes Due to Stability Data Concerns
Cantrell Drug Company is recalling 4,170 syringes of Heparin Sodium in 0.45% Sodium Chloride because stability data does not support the expiration date.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score (2) in the absence of reported injuries or illnesses, as the hazard is theoretical based on stability data rather than confirmed harm.
Plain-English summary
Cantrell Drug Company is recalling 4,170 syringes of Heparin Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL). The product is prescription-only and was distributed nationwide. The specific lot number is 6146, with an expiration date of 9/5/15.
The recall was initiated because stability data does not support the expiration date for this product. This is an FDA Class II recall, which indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Healthcare providers and patients should stop using the recalled product. Consumers should contact their healthcare provider for guidance on alternative treatments or replacements. The recalling firm is Cantrell Drug Company, located in Little Rock, AR.
The recalled product
- Product
- HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163
- Manufacturer
- Cantrell Drug Company
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 4,170
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 6146
- exp 9/5/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by Cantrell Drug Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Cantrell Drug Company
See all →- SevereCantrell Drug Company Recalls Rocuronium Bromide Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Succinylcholine Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Recalls Neostigmine Methylsulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
Same hazard · stability concern
See all →- HighEnoxaparin Sodium Injection recalled due to improper storage conditions
FDA (Drugs) · 2024-01-03
- ModeratePropranolol Hydrochloride 20 mg Tablets Recalled for Temperature Storage Deviations
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighNaloxone Injection Recall Due to Manufacturing Process Deviations
FDA (Drugs) · 2023-06-07
- HighAmantadine Hydrochloride Oral Solution Recalled Due to CGMP Deviations
FDA (Drugs) · 2023-06-07